Clyde Biosciences were delighted to present a total of four posters at the recent SPS meeting in Berlin, representing collobarations with major pharmaceutical companies. The posters showed:
- The influence of fibroblast co-culture and 3D structures on cardiac action potentials of human stem cell derived cardiomyocytes (Collaboration with Abbvie) AbbVie SPS FINAL
- Measurements of voltage, intracellular Ca2+ and contraction from spontaneous iPSC-derived cardiomyocytes using CellOPTIQ® platform reveals complex effects from drugs that parallel in vivo cardiac effects (Collaboration with Pfizer) Pfizer SPS FINAL
- Measurements of action potentials from iPSC-derived cardiomyocytes using CellOPTIQ® platform predicts both single ion channel effects and invitro whole heart electrophysiological responses (Collaboration with Orion Pharma) Orion SPS FINAL
- Measurements of action potentials, intracellular Ca2+ and contraction in stimulated isolated adult cardiomyocytes using CellOPTIQ® platform for lead development screening Clyde SPS FINAL
Each of these posters will shortly be made available for download.